lantan viatris 1000 mg tablete za žvakanje
viatris limited, damastown industrial park, mulhuddart, dublin, irska - lantan karbonat - tableta za žvakanje - 1000 mg - urbroj: jedna tableta za žvakanje od 1000 mg sadrži količinu lantan karbonat oktahidrata ekvivalentnu 1000 mg lantana
lantan viatris 500 mg tablete za žvakanje
viatris limited, damastown industrial park, mulhuddart, dublin, irska - lantan karbonat - tableta za žvakanje - 500 mg - urbroj: jedna tableta za žvakanje od 500 mg sadrži količinu lantan karbonat oktahidrata ekvivalentnu 500 mg lantana
lantan viatris 750 mg tablete za žvakanje
viatris limited, damastown industrial park, mulhuddart, dublin, irska - lantan karbonat - tableta za žvakanje - 750 mg - urbroj: jedna tableta za žvakanje od 750 mg sadrži količinu lantan karbonat oktahidrata ekvivalentnu 750 mg lantana
abakavir/lamivudin mylan pharma 600 mg/300 mg filmom obložene tablete
mylan ireland limited, unit 35/36 grange parade, baldoyle industrial estate, dublin 13, irska - abakavirsulfat lamivudin - filmom obložena tableta - 600 mg + 300 mg - urbroj: jedna filmom obložena tableta sadrži 600 mg abakavira (u obliku abakavirsulfata) i 300 mg lamivudina
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotska sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
jaglix 100 mg filmom obložene tablete
viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 100 mg sitagliptina
jaglix 25 mg filmom obložene tablete
viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 25 mg sitagliptina
jaglix 50 mg filmom obložene tablete
viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina
solifenacin stada 10 mg filmom obložene tablete
stada d.o.o., hercegovačka 14, zagreb, hrvatska - solifenacinsukcinat - filmom obložena tableta - 10 mg - urbroj: jedna filmom obložena tableta sadrži 10 mg solifenacinsukcinata, što odgovara 7,5 mg solifenacina
solifenacin stada 5 mg filmom obložene tablete
stada d.o.o., hercegovačka 14, zagreb, hrvatska - solifenacinsukcinat - filmom obložena tableta - 5 mg - urbroj: jedna filmom obložena tableta sadrži 5 mg solifenacinsukcinata, što odgovara 3,8 mg solifenacina